Abstract:The presence of large protein inclusions is a hallmark of neurodegeneration, and yet the precise molecular factors that contribute to their formation remain poorly understood. Screens using aggregation-prone proteins have commonly relied on downstream toxicity as a readout rather than the direct formation of aggregates. Here, we combined a genome-wide CRISPR knockout screen with Pulse Shape Analysis, a FACS-based method for inclusion detection, to identify direct modifiers of TDP-43 aggregation in human cells. Our screen revealed both canonical and novel proteostasis genes, and unearthed SRRD, a poorly characterized protein, as a top regulator of protein inclusion formation. APEX biotin labeling reveals that SRRD resides in proximity to proteins that are involved in the formation and breakage of disulfide bonds and to intermediate filaments, suggesting a role in regulation of the spatial dynamics of the intermediate filament network. Indeed, loss of SRRD results in aberrant intermediate filament fibrils and the impaired formation of aggresomes, including blunted vimentin cage structure, during proteotoxic stress. Interestingly, SRRD also localizes to aggresomes and unfolded proteins, and rescues proteotoxicity in yeast whereby its N-terminal low complexity domain is sufficient to induce this affect. Altogether this suggests an unanticipated and broad role for SRRD in cytoskeletal organization and cellular proteostasis. The presence of large protein inclusions is a hallmark of many neurodegenerative diseases, yet the precise mechanisms by which cells compartmentalize unfolded proteins is still not completely understood. Here we used a novel screening approach that enables FACS-based inclusion detection, to identify direct modifiers of TDP-43 aggregation in human cells. Our screen revealed both canonical and novel proteostasis genes, and unearthed SRRD, a poorly characterized protein, as a top regulator of protein inclusion formation. In follow up experiments, using both proximity labeling and imaging, we show that SRRD is involved in the regulation of intermediate filaments (IF) spatial organization. Loss of SRRD results in fragmented IF network and the reduced formation of aggresomes, which are transient compartments to which cells transfer unfolded proteins under cellular stress. Interestingly, without SRRD, aggresomes completely lack vimentin cages, which are typical structures that encapsulate aggresomes and have been associated with the recruitment of protein degradation and chaperones machinery to these structures. Altogether, we present a novel screening approach for the identification of gene associated with cellular proteostasis. We reveal several novel protein factors, including SRRD, which our data suggests has a broad and previously overlooked role cytoskeletal organization and protein quality control.

Septin regulation of Orai-mediated Ca2+ entry - a novel target for neurodegeneration

Pharmacological modulation of septins restores calcium homeostasis and is neuroprotective in models of Alzheimer's disease

Store-independent modulation of Ca(2+) entry through Orai by Septin 7

Rectifying Attenuated Store-Operated Calcium Entry As A Therapeutic Approach For Alzheimer'S Disease

Pharmacological regulation of endoplasmic reticulum structure and calcium dynamics: importance for neurodegenerative diseases

Targeting calciumopathy for neuroprotection: focus on calcium channels Cav1, Orai1 and P2X7

Dynamic behaviors of α-synuclein and tau in the cellular context: New mechanistic insights and therapeutic opportunities in neurodegeneration

Insights from Molecular Docking and Dynamics Simulations of P2RX7-𝛼Syn Complex

A cell autonomous regulator of neuronal excitability modulates tau in Alzheimer's disease vulnerable neurons

Determining the Roles of Inositol Trisphosphate Receptors in Neurodegeneration: Interdisciplinary Perspectives on a Complex Topic

Modulating mitochondrial calcium channels (TRPM2/MCU/NCX) as a therapeutic strategy for neurodegenerative disorders

SERCA pump as a novel therapeutic target for treating neurodegenerative disorders

Proteomic Analysis of Dynein-Interacting Proteins in Amyotrophic Lateral Sclerosis Synaptosomes Reveals Alterations in the RNA-Binding Protein Staufen1

Subcellular proteomics and iPSC modeling uncover reversible mechanisms of axonal pathology in Alzheimer's disease

Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade

Molecular Components of Store-Operated Calcium Channels in the Regulation of Neural Stem Cell Physiology, Neurogenesis, and the Pathology of Huntington’s Disease

Ca2+ homeostasis dysregulation in Alzheimer's disease: a focus on plasma membrane and cell organelles

Palmitoylated Sept8-204 modulates learning and anxiety by regulating filopodia arborization and actin dynamics

Intraneuronal sortilin aggregation relative to granulovacuolar degeneration, tau pathogenesis and sorfra plaque formation in human hippocampal formation

CRISPR screen for protein inclusion formation uncovers a role for SRRD in the regulation of intermediate filament dynamics and aggresome assembly

Dysregulated calcium signaling in the aged macaque entorhinal cortex associated with tau hyperphosphorylation.